BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBGS
1001
JBG SMITH
JBGS
$691M
| $8M | 0.01% |
253,992
+201,550
| +384% | +$6.57M |
|
1002
Vanguard S&P 500 ETF
VOO
$1.04T
| $8M | 0.01% |
20,329
+7,834
| +63% | +$3.01M |
|
1003
Bio-Rad Laboratories Class A
BIO
$9.68B
| $7.99M | 0.01% |
12,408
+11,340
| +1,062% | +$6.9M |
|
1004
Lear
LEA
$8.16B
| $7.96M | 0.01% |
45,424
+15,754
| +53% | +$2.91M |
|
1005
CALL
Freeport-McMoran
FCX
$93.6B
| $7.95M | 0.01% |
2,143
+1,700
| +384% | +$66.2K |
|
1006
Leggett & Platt
LEG
$1.29B
| $7.95M | 0.01% |
153,469
+71,300
| +87% | +$3.71M |
|
1007
PUT
Linde
LIN
$221B
| $7.95M | 0.01% |
275
| – | – |
|
1008
CALL
Lam Research
LRCX
$422B
| $7.94M | 0.01% |
1,220
-910
| -43% | -$57.4K |
|
1009
SS&C Technologies
SSNC
$18.8B
| $7.94M | 0.01% |
110,128
+48,741
| +79% | +$3.56M |
|
1010
Commerce Bancshares
CBSH
$8.61B
| $7.91M | 0.01% |
135,356
+82,203
| +155% | +$4.95M |
|
1011
Dolby
DLB
$5.84B
| $7.91M | 0.01% |
80,448
-62,094
| -44% | -$6.13M |
|
1012
Meritage Homes
MTH
$4.75B
| $7.9M | 0.01% |
167,854
+103,936
| +163% | +$5.25M |
|
1013
Steris
STE
$23.1B
| $7.89M | 0.01% |
38,231
-31,022
| -45% | -$6.25M |
|
1014
Idacorp
IDA
$8.21B
| $7.89M | 0.01% |
80,883
+11,738
| +17% | +$1.18M |
|
1015
PUT
T. Rowe Price
TROW
$23.8B
| $7.88M | 0.01% |
398
+295
| +286% | +$55.1K |
|
1016
CALL
Regeneron Pharmaceuticals
REGN
$82.2B
| $7.88M | 0.01% |
141
-25
| -15% | -$12.7K |
|
1017
PUT
ARK Innovation ETF
ARKK
$6.54B
| $7.85M | 0.01% |
600
-8,895
| -94% | -$1.04M |
|
1018
CALL
Western Digital
WDC
$168B
| $7.83M | 0.01% |
1,455
| – | – |
|
1019
Everest Group
EG
$13.9B
| $7.82M | 0.01% |
31,042
+10,543
| +51% | +$2.74M |
|
1020
Snap-on
SNA
$21.1B
| $7.79M | 0.01% |
34,858
+12,976
| +59% | +$3.11M |
|
1021
Builders FirstSource
BLDR
$7.79B
| $7.78M | 0.01% |
182,287
+91,883
| +102% | +$4.26M |
|
1022
PTC
PTC
$16.1B
| $7.75M | 0.01% |
54,898
-19,162
| -26% | -$2.62M |
|
1023
PUT
SolarEdge
SEDG
$1.98B
| $7.74M | 0.01% |
+280
| New | +$70.5K |
|
1024
Conduent
CNDT
$241M
| $7.7M | 0.01% |
1,026,664
+387,364
| +61% | +$2.83M |
|
|
1025
CALL
Linde
LIN
$221B
| $7.69M | 0.01% |
266
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.